Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Perimenopausal Depression
NCT00517985Phase 4Completed
- Sponsor
- University of Arizona
- Start
- Feb 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine in major depressive disorder (MDD), perimenopause, sponsored by University of Arizona. Started Feb 2007; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)perimenopause
Beyond the preview
Go deeper on NCT00517985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517985.